ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Basilea Pharmaceutica Ag

Basilea Pharmaceutica Ag (0QNA)

46.20
0.00
(0.00%)
Closed July 12 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
46.20
Bid
45.05
Ask
47.35
Volume
13
0.00 Day's Range 0.00
46.20 52 Week Range 46.20
Market Cap
Previous Close
46.20
Open
-
Last Trade
11
@
41.2
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,085
Shares Outstanding
12,002,000
Dividend Yield
-
PE Ratio
55.29
Earnings Per Share (EPS)
0.87
Revenue
150.28M
Net Profit
10.45M

About Basilea Pharmaceutica Ag

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Basel, Che
Founded
1970
Basilea Pharmaceutica Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QNA. The last closing price for Basilea Pharmaceutica was CHF46.20. Over the last year, Basilea Pharmaceutica shares have traded in a share price range of CHF 46.20 to CHF 46.20.

Basilea Pharmaceutica currently has 12,002,000 shares outstanding. The market capitalization of Basilea Pharmaceutica is CHF554.49 million. Basilea Pharmaceutica has a price to earnings ratio (PE ratio) of 55.29.

0QNA Latest News

Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation

Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage...

Basilea verpartnert Onkologie-Wirkstoffkandidat Lisavanbulin mit Glioblastoma Foundation

Basilea verpartnert Onkologie-Wirkstoffkandidat Lisavanbulin mit Glioblastoma Foundation Allschwil, 20. Juni 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches...

Starke Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus

Starke Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus Allschwil, 16. Mai 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX:...

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024 Allschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage...

Basilea berichtet über Präsentation neuer Daten zu Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2024

Basilea berichtet über Präsentation neuer Daten zu Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2024 Allschwil, 03. Mai 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...

Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats

Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats Allschwil, 24. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches...

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Basilea shareholders approve all proposals of the board of directors at the annual general meeting Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10046.246.246.286646.2DE
40046.246.246.2207046.2DE
120046.246.246.2208546.2DE
260046.246.246.2249046.2DE
520046.246.246.2379546.2DE
1560046.246.246.2469546.2DE
2600046.246.246.2402246.2DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7662
(138.69%)
102.09M
QLGNQualigen Therapeutics Inc
$ 0.3701
(80.27%)
384.58M
IVPInspire Veterinary Partners Inc
$ 9.0434
(61.78%)
34.13M
TOYOTOYO Company Ltd
$ 2.45
(58.06%)
53.86M
NISNNiSun International Enterprise Development Group Company Ltd
$ 8.77
(45.68%)
6.89M
SISIShineco Inc
$ 0.89
(-58.02%)
3.48M
HUBCWHub Cyber Security Ltd
$ 0.017
(-28.27%)
8.06k
MCACUMonterey Capital Acquisition Corporation
$ 7.66
(-28.21%)
30
KZIAKazia Therapeutics Ltd
$ 0.93398
(-24.68%)
20.56M
AEHLAntelope Enterprise Holdings Ltd
$ 4.74
(-20.47%)
669.83k
QLGNQualigen Therapeutics Inc
$ 0.3701
(80.27%)
384.58M
MAXNMaxeon Solar Technologies Ltd
$ 0.2393
(-0.58%)
244.73M
NVDANVIDIA Corporation
$ 131.1702
(2.96%)
166M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1015
(23.63%)
165.8M
LCIDLucid Group Inc
$ 4.219
(24.09%)
137.46M

Discussion

View Full Feed
waterchaser waterchaser 27 seconds ago
Apparently Godfater Capital is a scammer, just like his IHUB buddies.
HIRU
JRoon71 JRoon71 30 seconds ago
Capt, thanks for that info.

We are tracking in Canada exactly how we are tracking in the U.S.:

U.S. = $200M annual revenue / 333 Million people = $0.60 per person per year

Canada = $18M annual revenue / 31 Million people = $0.58 per person per year
AMRN
peafunke peafunke 37 seconds ago
2.7 billion in OS coming right up from series E and D conversions :/


https://fintel.io/doc/sec-tpt-global-tech-inc-1661039-8k-2024-july-12-19916-8721

Most likely because they know something’s coming?

TPTW
Lone Clone Lone Clone 38 seconds ago
Myriad Uranium Reports on Site Visit to Copper Mountain Uranium Project, Wyoming, USA

https://www.newsfilecorp.com/release/216259

July 12, 2024 7:30 AM EDT | Source: Myriad Uranium Corp.

Myriad Uranium holds a 75% earnable interest in the Copper Mount
GPS
i_like_bb_stock i_like_bb_stock 52 seconds ago
$VLCN took starter 3.80 the mkt seems to love low floaters with offerings like IVP so perhaps this runs
IVP VLCN
i_like_bb_stock i_like_bb_stock 58 seconds ago
$VLCN took starter 3.80 the mkt seems to love low floaters with offerings like IVP so perhaps this runs
IVP VLCN
dexprs dexprs 1 minute ago
Discounted preferred stocks and REITS will benefit from the rate cuts. REITS are rallying today, as they expect at least 1 25bp rate cut, perhaps in September and maybe two more this year.
D8c00p3r D8c00p3r 2 minutes ago
Might be one of the most limp wristed things I've ever seen you do TC.

Atleast now I understand you make it up as you go.

International Battery Metals Ltd. (the "Company"), is pleased to announce that is has appointed Marcum LLP, as the Company's independent registered
IBATF
Poo28 Poo28 2 minutes ago
It is indeed odd to use language like “to lead shareholders astray.?” Who speaks like that about a public country—Elmer Gantry howling at the moon.

FYI- shareholders know that there are a zillion different ways to establish a business, and those who have neither experience in the indu
DBMM
DewDiligence DewDiligence 2 minutes ago
MRK closes acquisition of (private) EyeBio:

https://www.businesswire.com/news/home/20240712972802/en
MRK
Nebuchadnezzar Nebuchadnezzar 2 minutes ago
AAPL MSFT NVDA cant add $5 to their stock prices everyday from current levels

the math just doesnt work even at current levels
AAPL MSFT NVDA
koolmc koolmc 2 minutes ago
yeah most are off and just trading part time during summer here and there, will pick up again heading into fall
Penny Stocks 2.0 Penny Stocks 2.0 2 minutes ago
$DPUI here come the bids, about to fly!!
DPUI
Penny Stocks 2.0 Penny Stocks 2.0 2 minutes ago
$DPUI here come the bids, about to fly!!
DPUI
PEACHMAN PEACHMAN 3 minutes ago
New legislation for IFUS to provide additional research and testing on alternative uses of bagasse is not wishful think dope

New college testing that has been happening for weeks at the Southern University of Baton Rouge is very real ya dope


Funding for resear
IFUS
AlaskaOTC AlaskaOTC 3 minutes ago
Looks like bud supports at 13. 16s cleared, small 14 blocking the bid at 13. Trips
Next week?
VXIT
JP313 JP313 3 minutes ago
Stock market so rigged
CDNO
LTListener LTListener 3 minutes ago
I dont think people are asking the right questions here.

While I would also like to know the answer to your question, the more important questions to me are:

How much is the KRM-ll-81 asset worth exiting preclinical stage and greenlighted for Human trials phase 1/2?
RSPI
Good time Charlie Good time Charlie 4 minutes ago
Hey trani3, you don't say much do you?
VDRM
koolmc koolmc 4 minutes ago
not until retail get's their fill, loi be closed by late third quarter, this is summer action, most can't wait that long.
GRLT
JJ8 JJ8 4 minutes ago
Ideal traders stock!
TSLA
LionsPride LionsPride 4 minutes ago
credentials still work hadnt been here in a few years
KZIA
mrwrn2010 mrwrn2010 4 minutes ago
Was Mikah involved at .03?
ELTP
PAC PAC 4 minutes ago
You're probably right. And demand for US bonds isnt as strong. So this major comes into play
SPY